An effective tool for healthcare professionals to support smoking cessation
Smoking is a leading contributor to Chronic Obstructive Pulmonary Disease (COPD). This condition often goes undetected and untreated in its initial phases, particularly among smokers.
A significant sign of COPD is a lower FEV1 compared to the expected FEV1 value. Detecting a decrease in FEV1 early can serve as an early alert to lung damage at a stage where quitting smoking is most beneficial.
The Vitalograph lung age device evaluates a person's FEV1 against standard values to determine their 'lung age'. A lung age that exceeds the individual's actual age can highlight the potential adverse effects of ongoing smoking on lung health and motivate cessation.